| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2012/08/09 | 21 : 24 | Dow Jones News | AstraZeneca: Bristol-Myers Squibb Completes Purchase of Amylin | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/08/09 | 05 : 11 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/08/08 | 22 : 19 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/08/08 | 21 : 40 | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/08/04 | 05 : 26 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/08/03 | 07 : 03 | Dow Jones News | 2nd UPDATE: Bristol-Myers Executive Charged With Insider Trading | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/08/03 | 03 : 00 | Dow Jones News | UPDATE: Bristol-Myers Executive Charged With Insider Trading | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/08/03 | 01 : 30 | Dow Jones News | Bristol-Myers Executive Charged With Insider Trading | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/08/03 | 01 : 17 | Dow Jones News | U.S. Charges Bristol-Myers Executive With Insider Trading | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/08/03 | 00 : 07 | Dow Jones News | Bristol-Myers Pension Executive Robert Ramnarine Arrested for Alleged Insider Trading -Bloomberg | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/08/01 | 21 : 15 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/08/01 | 20 : 49 | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/08/01 | 20 : 30 | Business Wire | Bristol-Myers Squibb Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Amylin Pharmaceuticals, ... | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/08/01 | 02 : 32 | Zacks | Solid Quarter at ALKS, View Backed - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/07/31 | 05 : 23 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/07/28 | 06 : 22 | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/07/28 | 06 : 13 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/07/28 | 06 : 10 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/07/27 | 09 : 08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/07/27 | 09 : 08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/07/27 | 09 : 07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/07/27 | 09 : 07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/07/27 | 09 : 07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/07/27 | 09 : 06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/07/27 | 09 : 06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/07/26 | 23 : 24 | Dow Jones News | Evercore 2nd-Quarter Profit Climbs 19% On Higher Investment Banking Revenue | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/07/25 | 21 : 20 | Dow Jones News | Bristol-Myers Profit Falls 28% | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/07/25 | 21 : 00 | Dow Jones News | Bristol-Myers 2nd-Quarter Profit Falls 28% on Drug-Patent Expirations | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/07/25 | 18 : 39 | Zacks | Generic Plavix Hurts Bristol-Myers - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 2012/07/25 | 18 : 39 | Zacks | Generic Plavix Hurts Bristol-Myers - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |